S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
Mazo DF, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira Alves VA, Carrilho FJ, de Oliveira CP. Drug Des Devel Ther. 2013:7:553–563. On page 554, the sentence "Therefore, we chose SNAC as a potential antifibrinogenic NO donor drug for treat...
Saved in:
Main Authors: | Mazo DF (Author), de Oliveira MG (Author), Pereira IV (Author), Cogliati B (Author), Stefano JT (Author), de Souza GF (Author), Rabelo F (Author), Lima FR (Author), Ferreira Alves VA (Author), Carrilho FJ (Author), de Oliveira CP (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
by: Mazo DF, et al.
Published: (2013) -
Oligonucleotide therapies for nonalcoholic steatohepatitis
by: Sixu Li, et al.
Published: (2024) -
Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023) -
Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
by: Mehmet Yalniz, et al.
Published: (2006) -
Bardet-Biedl syndrome with nonalcoholic steatohepatitis, hypertension, and hypothyroidism
by: Yatendra Singh, et al.
Published: (2016)